Nukkleus Inc. (NASDAQ:DFNS) Short Interest Down 48.2% in August

Nukkleus Inc. (NASDAQ:DFNSGet Free Report) was the recipient of a significant decline in short interest in August. As of August 14th, there was short interest totaling 144,490 shares, a decline of 48.2% from the July 30th total of 279,125 shares. Approximately 16.1% of the company’s stock are short sold. Based on an average trading volume of 2,406,740 shares, the days-to-cover ratio is currently 0.1 days.

Nukkleus Price Performance

DFNS stock traded down $0.34 on Monday, reaching $11.85. 433,851 shares of the company’s stock were exchanged, compared to its average volume of 1,358,502. The company has a quick ratio of 0.11, a current ratio of 0.14 and a debt-to-equity ratio of 0.07. The stock has a fifty day moving average of $23.58 and a 200-day moving average of $80.29. Nukkleus has a twelve month low of $3.70 and a twelve month high of $1,948.75. The firm has a market cap of $11.97 million, a PE ratio of -0.03 and a beta of -5.80.

Nukkleus (NASDAQ:DFNSGet Free Report) last posted its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The firm had revenue of $4.00 million for the quarter, compared to the consensus estimate of $4.50 million. As a group, equities analysts predict that Nukkleus will post -3.9 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Weiss Ratings lowered shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. Finally, Wall Street Zen upgraded shares of Nukkleus from a “strong sell” rating to a “sell” rating in a research report on Sunday, August 23rd. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Nukkleus has an average rating of “Moderate Buy”.

Get Our Latest Report on Nukkleus

Institutional Investors Weigh In On Nukkleus

A number of large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its holdings in Nukkleus by 193.7% during the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after acquiring an additional 82,252 shares in the last quarter. UBS Group AG grew its position in shares of Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares during the last quarter. LPL Financial LLC acquired a new stake in shares of Nukkleus in the fourth quarter valued at approximately $120,000. Engineers Gate Manager LP acquired a new stake in shares of Nukkleus in the fourth quarter valued at approximately $96,000. Finally, State Street Corp increased its stake in shares of Nukkleus by 70.7% during the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares in the last quarter. 12.47% of the stock is owned by institutional investors and hedge funds.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

See Also

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.